The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

BACKGROUND: There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2015
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://ncbi.nlm.nih.gov/pubmed/26509062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars